Your session is about to expire
← Back to Search
d-Amphetamine for Cocaine Use Disorder
Study Summary
This trial is testing a way to see how effective certain behavioral and pharmacological interventions are at reducing cocaine use.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have recently used cocaine.I have a serious physical or mental health condition.You are generally in good health.
- Group 1: Placebo Treatment
- Group 2: Active Treatment
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there an opportunity for recruitment currently available with this experiment?
"According to official records posted on clinicaltrials.gov, this research project is presently enrolling participants. The study was introduced on 15 January 2021 and most recently updated 11 March 2022."
Is there an opportunity to participate in this clinical examination?
"The team is seeking 18 volunteers, aged between 18 and 55 years old who have a diagnosis of cocaine use disorder. The ideal candidates would also be in otherwise good health and recently used the substance."
How many participants are partaking in this experimental research?
"Affirmative. Clinicaltrials.gov documents indicate that this clinical trial, which was initially posted on January 15th 2021, is actively searching for participants. 18 subjects need to be enlisted from one site in total."
Are there precedents for trials involving Sustained Release d-amphetamine?
"Currently, 8 medical studies are exploring the effects of Sustained Release d-amphetamine with 1 trial in its final stage. 11 healthcare facilities across the country host these trials and one such centre is located in Atlanta, Georgia."
Is there an age ceiling for participation in this experiment?
"To be included in this medical trial, applicants must fall between 18-55 years old. Alternatively, there are two dedicated studies for minors and thirteen specialised trials targeting elderly individuals over the age of 65."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger